Loading…

A novel, comprehensive tool for predicting 30-day mortality after surgical aortic valve replacement

Abstract OBJECTIVES We sought to develop and validate a novel risk assessment tool for the prediction of 30-day mortality after surgical aortic valve replacement incorporating a patient’s frailty. METHODS Overall, 4718 patients from the multicentre study OBSERVANT was divided into derivation (n = 35...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cardio-thoracic surgery 2021-04, Vol.59 (3), p.586-592
Main Authors: Biancari, Fausto, Rosato, Stefano, Costa, Giuliano, Barbanti, Marco, D’Errigo, Paola, Tamburino, Corrado, Cerza, Francesco, Rosano, Aldo, Seccareccia, Fulvia
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract OBJECTIVES We sought to develop and validate a novel risk assessment tool for the prediction of 30-day mortality after surgical aortic valve replacement incorporating a patient’s frailty. METHODS Overall, 4718 patients from the multicentre study OBSERVANT was divided into derivation (n = 3539) and validation (n = 1179) cohorts. A stepwise logistic regression procedure and a criterion based on Akaike information criteria index were used to select variables associated with 30-day mortality. The performance of the regression model was compared with that of European System for Cardiac Operative Risk Evaluation (EuroSCORE) II. RESULTS At 30 days, 90 (2.54%) and 35 (2.97%) patients died in the development and validation data sets, respectively. Age, chronic obstructive pulmonary disease, concomitant coronary revascularization, frailty stratified according to the Geriatric Status Scale, urgent procedure and estimated glomerular filtration rate were independent predictors of 30-day mortality. The estimated OBS AVR score showed higher discrimination (area under curve 0.76 vs 0.70, P 
ISSN:1010-7940
1873-734X
DOI:10.1093/ejcts/ezaa375